| Title |
Duloxetine for treating painful neuropathy or chronic pain
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, October 2009
|
| DOI | 10.1002/14651858.cd007115.pub2 |
| Pubmed ID | |
| Authors |
Lunn, Michael PT, Hughes, Richard AC, Wiffen, Philip J |
| Abstract |
Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| United States | 2 | 2% |
| Spain | 1 | <1% |
| Hong Kong | 1 | <1% |
| Unknown | 98 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 15% |
| Student > Master | 16 | 15% |
| Student > Bachelor | 10 | 10% |
| Student > Ph. D. Student | 10 | 10% |
| Student > Postgraduate | 10 | 10% |
| Other | 17 | 16% |
| Unknown | 25 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 33% |
| Psychology | 11 | 11% |
| Nursing and Health Professions | 7 | 7% |
| Chemistry | 5 | 5% |
| Agricultural and Biological Sciences | 4 | 4% |
| Other | 15 | 14% |
| Unknown | 28 | 27% |